Spain’s Grifols gives new details on past EBITDA, leverage ratios to supervisor
MADRID (Reuters) – Spanish drugmaker Grifols on Thursday issued new details of its 2022 and 2023 accounts, including higher leverage ratios than previously reported based on a different calculation of its core earnings and debt, after it was required to do so by market supervisor CNMV. The new calculation is based on profit-and-loss balance sheets …
Spain’s Grifols gives new details on past EBITDA, leverage ratios to supervisor Read More »









